Bitterman Robert J 4
4 · Phio Pharmaceuticals Corp. · Filed Jun 11, 2025
Insider Transaction Report
Form 4
Bitterman Robert J
DirectorChairman, Pres. & CEO
Transactions
- Purchase
Common Stock, $0.0001 par value
2025-06-10$2.42/sh+2,000$4,840→ 27,149 total
Footnotes (1)
- [F1]Includes shares of common stock underlying unvested restricted stock units.